NGM Biopharmaceuticals Inc (NASDAQ:NGM)
| 3.39 Delayed Data As of 3:59pm ET |  -0.05 / -1.45%Today’s Change | 2.84 Today|||52-Week Range 18.25 | -32.47% Year-to-Date |
Latest NGM News | Press Releases
No recent news for NGM Biopharmaceuticals Inc.
Today’s Trading
| Previous close | 3.44 |
| Today’s open | 3.43 |
| Day’s range | 3.39 - 3.68 |
| Volume | 10,380 |
| Average volume (3 months) | 305,300 |
| Market cap | $269.3M |
Data as of 3:59pm ET, 06/09/2023
Growth & Valuation
| Earnings growth (last year) | -30.33% |
| Earnings growth (this year) | +6.82% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -28.95% |
| P/E ratio | NM |
| Price/Sales | 7.25 |
| Price/Book | 1.02 |
Competitors
Data as of 4:00pm ET, 06/09/2023
Financials
| Next reporting date | August 15, 2023 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $55.3M |
| Annual profit (last year) | -$162.7M |
| Net profit margin | -293.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
